课题基金 / 基金详情

P53-Mediated G1/M Checkpoint Controls Altered by PPM1D

P53-Mediated G1/M Checkpoint Controls Altered by PPM1D
PPM1D 改变的 P53 介导的 G1/M 检查点控制
批准号:
7350950
负责人:
Arthur M. BUCHBERG
金额:
$23.89万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1999
资助国家:
美国
项目状态:
已结题
起止时间:
1999-01-01 至 2011-02-28

项目摘要

项目成果

Arthur M. BUCHBERG的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
P53-Mediated Gl/M Checkpoint Controls Altered by PPM1D The p53 tumor suppressor protein is a sequence-specific transcription factor that modulates the response of cells to genotoxic stress and other forms of cellular stress. PPM1D (formally called Wipl) is transcriptionally-activated in response to genotoxic stress in a p53-dependent manner. It encodes a protein phosphatase that targets the stress induced kinase p38MAPK which disrupts the p38MAPK-p53 signalingpathway. This is correlated with alterations in the pattern of N-terminal phosphorylation on p53 protein. N-terminal phosphorylation is important for p53 protein to function as a trariscriptional factor. We and others have shown that forced exogenous expression of PPM ID attenuates the apoptotic response to DNA-damaging agents. Decreasing PPM1D in human tumor cells that constitutively over express it due to gene amplification enhances the apoptotic response to chemotherapeutic agents. This is correlated with changes,in the level of expression of the pro-apoptotic Bax gene.The goal of this project is to elucidate the mechanistic basis and the role that PPM1D plays in modulatingthe transcriptional activity of p53.The hypothesis to be tested is that disruption of the p38MAPK-p53 signaling pathway by PPM1D affects p53-mediated transcription of responsive genes involved in cell cycle checkpoint control and/or apoptosis. The Specific Aims are the following: 1) To determine if PPM ID-mediated disruptionof p38MAPK-p53 signalingalters the interaction between p53 protein and p53-responsive elements of downstream target genes. 2) To determine if PPMID-mediated disruptionof p38MAPK-p53 signaling alters the interaction of p53 protein with transcriptional coactivators. 3) To identify and characterize genes whose expression is altered by PPM ID-mediated disruption of the p38MAPK-p53 signaling pathway. Lay Abstract: PPM1D is a new player in the p53 network about which we know very little at present. The PPM1D gene is often amplified in human breast, ovarian and neuroblastoma tumors that harbor a wild type p53 gene. This project will provide new informationregarding the role that PPM1D plays in the p53 network involved in cell cycle control and apopotosis and elucidate the mechanistic basis for this action.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Lab Animal
  • 批准号:
    8302936
  • 项目类别:
  • 资助金额:
    $19.73万
  • 财政年份:
    2011
  • 负责人:
    Arthur M. BUCHBERG
  • 依托单位:
Lab Animal
  • 批准号:
    8084093
  • 项目类别:
  • 资助金额:
    $20.91万
  • 财政年份:
    2010
  • 负责人:
    Arthur M. BUCHBERG
  • 依托单位:
Sensitized screen to identify cooperating genes involved in pancreatic cancer
  • 批准号:
    7660263
  • 项目类别:
  • 资助金额:
    $20.39万
  • 财政年份:
    2009
  • 负责人:
    Arthur M. BUCHBERG
  • 依托单位:
Activation of Innate Immunity Effector Cells
  • 批准号:
    7002695
  • 项目类别:
  • 资助金额:
    $34.49万
  • 财政年份:
    2003
  • 负责人:
    Arthur M. BUCHBERG
  • 依托单位:
国内基金
海外基金
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
  • 批准号:
    LBY21H010001
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2020
  • 负责人:
    郑绪阳
  • 依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
  • 批准号:
    81703335
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    20.0万元
  • 批准年份:
    2017
  • 负责人:
    卫高菲
  • 依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
  • 批准号:
    81670594
  • 项目类别:
    面上项目
  • 资助金额:
    58.0万元
  • 批准年份:
    2016
  • 负责人:
    陈昊
  • 依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
  • 批准号:
    81470791
  • 项目类别:
    面上项目
  • 资助金额:
    73.0万元
  • 批准年份:
    2014
  • 负责人:
    董家鸿
  • 依托单位: